
Amended by No I of the O of 7 June 2024, in force since 1 March 2025 (AS 2024 322).
English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.
1 The sponsor must register and publish an authorised clinical trial by entering the data specified in Annex 5 number 1: a. in a primary registry recognised by the World Health Organization (WHO); or b. in the registry of the U.S. National Library of Medicine. 2 The sponsor shall additionally enter the data specified in Annex 5 numbers 2.1–2.9, using the Swiss national languages in which recruitment is planned, in the cantonal information system specified in Article 56a HRA. 2bis For Phase I clinical trials in which the medicinal product under investigation is administered exclusively to adults, the data specified in Annex 5 number 3.1 may initially be excluded from entry in accordance with paragraphs 1, 2 and 4; it must however be entered and automatically published at the latest within the period specified in Annex 5 number 3.2. 3 The data must be entered in the version approved by the responsible ethics committee. It must be regularly updated. 4 Registration and entry in accordance
Amended by No I of the O of 7 June 2024, in force since 1 March 2025 (AS 2024 322). Amended by No I of the O of 7 June 2024, in force since 1 March 2025 (AS 2024 322). The registries can be consulted at: www.who.int/ > Programmes and projects > Clinical Trials – International Registry Platform. The registry can be consulted at: www.clinicaltrials.gov . Amended by No I of the O of 7 June 2024, in force since 1 March 2025 (AS 2024 322). Inserted by No I of the O of 7 June 2024, in force since 1 Ma
The sponsor is responsible for the accuracy and completeness of the data entered.
1 The FOPH shall operate a portal ensuring public access to information on clinical trials conducted in Switzerland via online access to one or more registries. 2 The portal shall enable in particular the linking of data to be entered under Articles 64 and 65a, as well as Articles 41 and 42 ClinO-MD, and the publication of this and other data from the cantonal information system as specified in Annex 5.
Art. 67 — Amended by No I of the O of 7 June 2024, in force since 1 March 2025 (AS 2024 322). Para. 2 — SR 810.306